Shares of vaccine makers such as Moderna (MRNA) and Pfizer (PFE) have plunged on news that president-elect Donald <a ...

Experts warn of an expected winter COVID-19 surge, potentially impacting marginalized communities that have faced ...

Kennedy has promised to "Make America Healthy Again" by tackling obesity with nutrition. Here's how he could rattle the ...

Other drug manufacturers declined in the days following the nomination. Pfizer and Moderna have declined 6.9% and 6.2% ...

Levi & Korsinsky, LLP notifies investors in Metagenomi, Inc. ("Metagenomi" or the "Company") of a class action securities ...

Donald Trump's appointment of Robert F Kennedy Junior as health czar means interesting times for US-focused ASX life sciences ...

The S&P 500 added 0.4% on Tuesday, Nov. 19, as investors digested a strong report from a major retailer and awaited more ...

It started as a minor disagreement. Since then, Supervisor Belia Ramos, in her first in-depth interview on the subject, says ...

BANGKOK (AP) — Asian shares advanced Tuesday, apart from in China, after most U.S. stocks ticked higher to recover some of ...

Stock markets in Canada and the U.S. fell Friday as investors began to digest the implications of a Donald Trump presidency.

HSBC analyst Yifeng Liu upgraded Moderna (MRNA) to Buy from Hold with a price target of $58, down from $82. The recent share ...

Leerink Partners analyst Mani Foroohar has reiterated their bearish stance on MRNA stock, giving a Sell rating on November 14.Don't Miss our ...